BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38050673)

  • 1. Visualizing Dipeptidyl Peptidase-IV with an Advanced Non-π-Conjugated Fluorescent Probe for Early Thyroid Disease Diagnosis.
    Li J; Ma M; Li J; Xu L; Song D; Ma P; Fei Q
    Anal Chem; 2023 Dec; 95(48):17577-17585. PubMed ID: 38050673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of a water-soluble near-infrared fluorescent probe for selective detection and imaging of dipeptidyl peptidase IV in biological systems.
    Guo X; Mu S; Li J; Zhang Y; Liu X; Zhang H; Gao H
    J Mater Chem B; 2020 Jan; 8(4):767-775. PubMed ID: 31897456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly specific ratiometric two-photon fluorescent probe to detect dipeptidyl peptidase IV in plasma and living systems.
    Zou LW; Wang P; Qian XK; Feng L; Yu Y; Wang DD; Jin Q; Hou J; Liu ZH; Ge GB; Yang L
    Biosens Bioelectron; 2017 Apr; 90():283-289. PubMed ID: 27923191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activatable Near-Infrared Fluorescent Probe for Dipeptidyl Peptidase IV and Its Bioimaging Applications in Living Cells and Animals.
    Liu T; Ning J; Wang B; Dong B; Li S; Tian X; Yu Z; Peng Y; Wang C; Zhao X; Huo X; Sun C; Cui J; Feng L; Ma X
    Anal Chem; 2018 Mar; 90(6):3965-3973. PubMed ID: 29493228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of early adenocarcinoma of the esophagogastric junction by spraying an enzyme-activatable fluorescent probe targeting Dipeptidyl peptidase-IV.
    Yamamoto K; Ohnishi S; Mizushima T; Kodaira J; Ono M; Hatanaka Y; Hatanaka KC; Kuriki Y; Kamiya M; Ehira N; Shinada K; Takahashi H; Shimizu Y; Urano Y; Sakamoto N
    BMC Cancer; 2020 Jan; 20(1):64. PubMed ID: 31992267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratiometric Two-Photon Near-Infrared Probe to Detect DPP IV in Human Plasma, Living Cells, Human Tissues, and Whole Organisms Using Zebrafish.
    Valverde-Pozo J; Paredes JM; Widmann TJ; Griñan-Lison C; Ceccarelli G; Gioiello A; Garcia-Rubiño ME; Marchal JA; Alvarez-Pez JM; Talavera EM
    ACS Sens; 2023 Mar; 8(3):1064-1075. PubMed ID: 36847549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Wavelength Ratiometric Fluorescent Probe for the Early Diagnosis of Diabetes.
    Wang J; Zhang L; Qu Y; Yang Y; Cao T; Cao Y; Iqbal A; Qin W; Liu Y
    Anal Chem; 2021 Aug; 93(33):11461-11469. PubMed ID: 34369744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive significance of serum dipeptidyl peptidase-IV in papillary thyroid carcinoma.
    Zhang N; Cong X; Zhou D; Guo L; Yuan C; Xu D; Su C
    Cancer Biomark; 2019; 24(1):7-17. PubMed ID: 30594915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
    Lee JJ; Wang TY; Liu CL; Chien MN; Chen MJ; Hsu YC; Leung CH; Cheng SP
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2930-2940. PubMed ID: 28575350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel non-enzymatic hydrolytic probe for dipeptidyl peptidase IV specific recognition and imaging.
    Xing J; Gong Q; Zhang R; Sun S; Zou R; Wu A
    Chem Commun (Camb); 2018 Aug; 54(63):8773-8776. PubMed ID: 30035284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fluorescent switchable AIE probe for selective imaging of dipeptidyl peptidase-4 in vitro and in vivo and its application in screening DPP-4 inhibitors.
    Wang Y; Wu X; Cheng Y; Zhao X
    Chem Commun (Camb); 2016 Feb; 52(17):3478-81. PubMed ID: 26812581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective fluorescence probes for dipeptidyl peptidase activity-fibroblast activation protein and dipeptidyl peptidase IV.
    Lai KS; Ho NH; Cheng JD; Tung CH
    Bioconjug Chem; 2007; 18(4):1246-50. PubMed ID: 17489551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red Fluorescence Probe Targeted to Dipeptidylpeptidase-IV for Highly Sensitive Detection of Esophageal Cancer.
    Ogasawara A; Kamiya M; Sakamoto K; Kuriki Y; Fujita K; Komatsu T; Ueno T; Hanaoka K; Onoyama H; Abe H; Tsuji Y; Fujishiro M; Koike K; Fukayama M; Seto Y; Urano Y
    Bioconjug Chem; 2019 Apr; 30(4):1055-1060. PubMed ID: 30920803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and sensitive detection of early esophageal squamous cell carcinoma with fluorescence probe targeting dipeptidylpeptidase IV.
    Onoyama H; Kamiya M; Kuriki Y; Komatsu T; Abe H; Tsuji Y; Yagi K; Yamagata Y; Aikou S; Nishida M; Mori K; Yamashita H; Fujishiro M; Nomura S; Shimizu N; Fukayama M; Koike K; Urano Y; Seto Y
    Sci Rep; 2016 Jun; 6():26399. PubMed ID: 27245876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in dipeptidyl peptidase IV activity is linked to the efficacy of differentiating compounds in follicular thyroid carcinoma cell lines.
    Fröhlich E; Engel E; Wahl R
    Horm Metab Res; 2011 May; 43(5):364-6. PubMed ID: 21412686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-infrared probe for early diagnosis of diabetic complications-nephropathy and in vivo visualization fluorescence imaging research.
    Wang J; Zhang L; Qin W; Liu Y
    Anal Chim Acta; 2022 Aug; 1221():340147. PubMed ID: 35934391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase IV Inhibitory activity of Terminalia arjuna attributes to its cardioprotective effects in experimental diabetes: In silico, in vitro and in vivo analyses.
    Mohanty IR; Borde M; Kumar C S; Maheshwari U
    Phytomedicine; 2019 Apr; 57():158-165. PubMed ID: 30668318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl Peptidase-4 Stabilizes Integrin α4β1 Complex to Promote Thyroid Cancer Cell Metastasis by Activating Transforming Growth Factor-Beta Signaling Pathway.
    He Q; Cao H; Zhao Y; Chen P; Wang N; Li W; Cui R; Hou P; Zhang X; Ji M
    Thyroid; 2022 Nov; 32(11):1411-1422. PubMed ID: 36166219
    [No Abstract]   [Full Text] [Related]  

  • 19. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
    Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW
    Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV.
    Marchetti C; Di Carlo A; Facchiano F; Senatore C; De Cristofaro R; Luzi A; Federici M; Romani M; Napolitano M; Capogrossi MC; Germani A
    Diabetologia; 2012 Jan; 55(1):236-44. PubMed ID: 21656024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.